Endoplasmic Reticulum Stress in Neurodegenerative Diseases
Journal of Dementia and Alzheimer's Disease · 2024
DOI: 10.3390/jdad1020006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Dementia and Alzheimer's Disease, 2024. Verfasst von Syed-Abdul-Moiz Hasan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, The University of Toledo, Toledo, OH 43614…. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke of the National Institutes of Health.
Abstract (Originalsprache)
Endoplasmic reticulum (ER) stress is a detrimental cellular phenomenon in the cells and is activated by the accumulation of unfolded or misfolded proteins in the ER. The unfolded protein accumulation activates the unfolded protein response (UPR), an adaptive mechanism designed to mitigate cellular stress by enhancing the ER’s protein-folding capacity and protecting cells from apoptotic stimuli in neuroinflammation and neurodegenerative diseases. However, chronic ER stress and prolonged activation of the UPR can have adverse effects, including the activation of pro-apoptotic and inflammatory signaling pathways, which contribute to the development and progression of neurodegenerative disorders. Neurodegenerative diseases are complex and devastating conditions with underlying pathogenesis that are not fully understood. Genetic mutations leading to the accumulation of misfolded or phosphorylated tau proteins and amyloid-beta in the ER can induce ER stress, resulting in neuroinflammation and neuronal death. Several studies have reported the involvement of increased ER stress and UPR signaling proteins in the pathogenesis and progression of neurodegenerative diseases. Thus, inhibiting ER stress and neuroinflammation and targeting their associated signaling pathways represent a significant area of research interest. This review discusses the critical signaling molecules involved in ER stress, their mechanisms in the progression of neurodegenerative diseases, and the latest developments in the available ER stress inhibitors. Despite the extensive development of ER stress inhibitors over the years, only a limited number have been approved as pharmaceutical drugs. There remains a critical need for effective ER stress inhibitors to provide efficient treatments for neurodegenerative diseases, including Alzheimer’s disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, The University of Toledo, Toledo, OH 43614, USA.
- Department of Medicinal and Biological Chemistry, College of Pharmacy and Pharmaceutical Sciences, The University of Toledo, Toledo, OH 43614, USA.
ORCID-Profile: Zahoor A Shah
Förderung
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke of the National Institutes of Health
Zitieren
APA
Hasan, S. A., James, A. W., Fazili, F. M., Tarabishi, S., Sheikh, N. M., & Shah, Z. A. (2024). Endoplasmic Reticulum Stress in Neurodegenerative Diseases. Journal of Dementia and Alzheimer's Disease. https://doi.org/10.3390/jdad1020006
Vancouver
Hasan SA, James AW, Fazili FM, Tarabishi S, Sheikh NM, Shah ZA. Endoplasmic Reticulum Stress in Neurodegenerative Diseases. Journal of Dementia and Alzheimer's Disease. 2024. doi:10.3390/jdad1020006
BibTeX
@article{Hasan2024,
author = {Hasan, Syed-Abdul-Moiz and James, Antonisamy William and Fazili, Farzeen M and Tarabishi, Samiha and Sheikh, Namir M and Shah, Zahoor A},
title = {Endoplasmic Reticulum Stress in Neurodegenerative Diseases},
journal = {Journal of Dementia and Alzheimer's Disease},
year = {2024},
doi = {10.3390/jdad1020006}
}
EUVIMED